Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Acta 1830, 31433153
UK patients should understand that: Available evidence is largely from Phase 2 studies with relatively short follow-up periods Long-term cardiovascular outcome data are not yet available for either agent Phase 3 trials are ongoing, and results will inform future regulatory submissions to the MHRA UK patients interested in accessing these treatments through clinical trials may wish to consult the NIHR 'Be Part of Research' portal (bepartofresearch.nihr.ac.uk) or ClinicalTrials.gov for current recruitment opportunities
or subscribe and save 10% We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits
P.MadhyasthaS
US$ 25.95
US$ 26.40
US$ 22.43
US$ 29.21
